HCV protein-induced cytokine predicts treatment outcomes in chronic hepatitis C virus infection

被引:0
|
作者
Krueger, Carla [1 ,2 ]
Collister, Mark [1 ,2 ]
Minuk, Gerald Y. [1 ]
Janke, Alyssa [1 ]
Lerner, Jordyn [1 ]
Wong, Stephen G. M. [1 ]
Rempel, Julia D. [1 ,2 ]
机构
[1] Univ Manitoba, Dept Med, Sect Hepatol, Winnipeg, MB R3E 3P4, Canada
[2] Univ Manitoba, Dept Immunol, Winnipeg, MB R3E 3P4, Canada
关键词
adipokines; core; hepatitis C virus; NS3; sustained viral response; TNF-alpha; NECROSIS-FACTOR-ALPHA; INDUCED INSULIN-RESISTANCE; RHEUMATOID-ARTHRITIS; SERUM-LEVELS; PSORIATIC-ARTHRITIS; ETANERCEPT THERAPY; ADIPONECTIN LEVELS; EGYPTIAN PATIENTS; INTERFERON-ALPHA; LIVER STEATOSIS;
D O I
10.1111/liv.12418
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background & Aims: Immune-mediated processes are thought to influence the efficacy of treatment in chronic hepatitis C virus (HCV) infection. This study evaluated the association of baseline immune responses with the achievement of a sustained viral response (SVR) upon pegylated interferon and ribavirin treatment. Methods: Baseline serum and peripheral blood mononuclear cells (PBMC) cytokine activity was assessed. Metabolic and liver injury parameters were evaluated as underlying factors. Results: Baseline demographics and disease parameters did not differ between the SVR - (n = 14) and SVR+ (n = 25) cohorts except for body mass index (BMI) values and liver injury scores. Baseline circulating TNF-alpha levels were three-fold higher with subsequent treatment failure vs. success (P = 0.124). Baseline peripheral blood mononuclear cells (PBMC, n = 25) were cultured with HCV core and non-structural (NS)3 proteins. Core (P = 0.0003) and NS3 (P = 0.018) induced greater TNF-alpha production within the SVR-, compared with the SVR+, cohorts. Similar findings were noted for interleukin (IL)-1 beta and IL-10 synthesis. Furthermore, HCV core-induced TNF-alpha synthesis correlated with patient BMI values (r = 0.489, P = 0.015). Core (r = 0.432, P = 0.065) and NS3 (r = 0.530, P = 0.020)-induced TNF-alpha displayed a positive relationship with serum adiponectin concentrations. In addition, lipopolysaccharide stimulated cytokine synthesis associated with BMI and adiponectin levels. Although unable to predict treatment outcomes, NS3-induced IL-6 synthesis and serum leptin concentrations corresponded to liver injury scores. Conclusion: An enhanced PBMC susceptibility to core and NS3-induced TNF-alpha synthesis at baseline was associated with treatment failure. This phenomenon appeared to involve the interaction of virally generated TNF-alpha activity and metabolic disease. In contrast, IL-6 activity and leptin levels may indicate liver damage.
引用
收藏
页码:E62 / E70
页数:9
相关论文
共 50 条
  • [41] Association of Chronic Hepatitis C Virus Infection and Cardiovascular Outcomes
    Wubiee, Firew M.
    Howell, Charles D.
    GASTROENTEROLOGY, 2015, 148 (04) : S1103 - S1103
  • [42] Assessment of motivating factors associated with the initiation and completion of treatment for chronic hepatitis C virus (HCV) infection
    Lauren Fusfeld
    Jyoti Aggarwal
    Carly Dougher
    Montserrat Vera-Llonch
    Stephen Bubb
    Mrudula Donepudi
    Thomas F Goss
    BMC Infectious Diseases, 13
  • [43] Assessment of motivating factors associated with the initiation and completion of treatment for chronic hepatitis C virus (HCV) infection
    Fusfeld, Lauren
    Aggarwal, Jyoti
    Dougher, Carly
    Vera-Llonch, Montserrat
    Bubb, Stephen
    Donepudi, Mrudula
    Goss, Thomas F.
    BMC INFECTIOUS DISEASES, 2013, 13
  • [44] The spectrum of chronic hepatitis C virus (HCV) infection in African Americans (AA)
    Gill, R
    Salvatori, JJ
    Hofmann, CM
    Sterling, RK
    Luketic, VA
    Sanyal, AJ
    Shiffman, ML
    GASTROENTEROLOGY, 2001, 120 (05) : A367 - A367
  • [45] Therapeutic vaccination for chronic hepatitis C virus infection in HCV trimera mice
    Rahman, F
    Blust, N
    Baumert, T
    Geissler, M
    Galle, PP
    Böcher, WO
    HEPATOLOGY, 2005, 42 (04) : 532A - 532A
  • [46] REDUCING THE DISEASE BURDEN OF CHRONIC HEPATITIS C VIRUS (HCV) INFECTION IN ENGLAND
    Rosenberg, W. M.
    Cramp, M.
    Davis, M.
    Parkes, J.
    Ryder, S.
    Razavi, H.
    Hindman, S.
    JOURNAL OF HEPATOLOGY, 2014, 60 (01) : S333 - S334
  • [47] Cryoglobulinemic and noncryoglobulinemic neuropathy in chronic hepatitis C virus (HCV) infection.
    Wilson, L
    Reichler, B
    Gorevic, PD
    ARTHRITIS AND RHEUMATISM, 2000, 43 (09): : S192 - S192
  • [48] Prevalence of ANCA in chronic hepatitis C virus (HCV) infection sequelae.
    Lamprecht, P
    Gutzeit, O
    Csernok, E
    Longombardo, G
    Gause, A
    Gross, WL
    Ferri, C
    ARTHRITIS AND RHEUMATISM, 2000, 43 (09): : S126 - S126
  • [49] Lack of association between hepatitis C virus (HCV) infection and chronic urticaria
    Zauli, D
    Grassi, A
    Lari, F
    Bortolotti, R
    Ballardini, G
    Bianchi, FB
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2001, 107 (02) : S52 - S52
  • [50] Hepatitis C Virus (HCV) Infection in New Zealand: Burden of Chronic Disease
    Gane, Edward J.
    Brunton, Cheryl R.
    Estes, Chris
    Henderson, Charles
    Hornell, John
    Radke, Sarah
    Razavi, Homie
    Stedman, Catherine A.
    HEPATOLOGY, 2014, 60 : 913A - 914A